Spots Global Cancer Trial Database for Tissue Characterisation by Endoscopic GI-elastography

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tissue Characterisation by Endoscopic GI-elastography

Official Title: Tissue Characterisation Using Ultrasound Based Strain Imaging(Elastography)Examining Lesions in the Gastrointestinal Wall, Adjacent Lymph Nodes and Pancreatic Lesions

Study ID: NCT01360411

Conditions

Disorder of Upper Gastrointestinal Tract

Pancreatic Nodule

Secondary and Unspecified Malignant Neoplasm of Retroperitoneal Lymph Nodes

Secondary Malignant Neoplasm of Lymph Node

Interventions

Study Description

Brief Summary: In this single centre study we study the use of endoscopic ultrasonography (EUS) combined with elastography in order to separate malignant tissue from benign tissue in and adjacent to the upper gastrointestinal tract.

Detailed Description: The purpose of this study is to use endoscopic ultrasonography (EUS) with strain based elastography to identify strain traits separating malignant from benign lesions. We are registering feasibility of endoscopic strain imaging and compare diagnostic accuracy of EUS + elastography with previous data on EUS alone. Inclusion criteria: * Group 1: Focal subepithelial lesions in esophageal, ventricular or duodenal wall discovered by endoscopy or other imaging modality. * Group 2: Pancreatic lesion discovered by other imaging modality. * Group 3: Mediastinal or retroperitoneal lymph node or tumor discovered by other imaging modality. Histology of lesions should not be known at the time of examination. EUS elastography findings are evaluated shortly after the examination and categorised by different methods; categorical score, VAS, Strain Ratio. The result is then compared to histology or cytology results. Patients who do not undergo tissue sampling are followed up to discover disease progress.